Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.96 |
| ▸ | PPARD | Q03181 | 5/20 | 0.96 |
| ▸ | PPARA | Q07869 | 5/20 | 0.96 |
| ▸ | F7 | P08709 | 5/20 | 0.96 |
| ▸ | F3 | P13726 | 5/20 | 0.96 |
| ▸ | TERT | O14746 | 3/20 | 0.96 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.96 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.96 |
| ▸ | FABP4 | P15090 | 3/20 | 0.96 |
| ▸ | TOP1 | P11387 | 3/20 | 0.96 |
| ▸ | MAPT | P10636 | 2/20 | 0.96 |
| ▸ | BLM | P54132 | 2/20 | 0.96 |
| ▸ | LMNA | P02545 | 2/20 | 0.96 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.96 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.96 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.96 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.96 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.96 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.96 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.96 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oleic Acid SCHEMBL1643154 | 1.00 | PPARG (0.96) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL20577298 | 0.98 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL22608055 | 0.98 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| Oleic Acid SCHEMBL20975500 | 0.98 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL25424711 | 0.98 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| Vaccenic Acid SCHEMBL25298899 | 0.98 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| Oleic Acid SCHEMBL25289881 | 0.98 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| Palmitoleic Acid SCHEMBL25293293 | 0.98 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL22608051 | 0.98 | PPARG (1.00) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL22608052 | 0.98 | PPARG (1.00) | PPARGPPARDPPARAF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110964528-B | Quantum dot and preparation method thereof | TCL科技集团股份有限公司 | 2022-01-21 | — | — | CN | claimed |
| CN-111718710-A | Preparation method of quantum dots | TCL集团股份有限公司 | 2020-09-29 | — | — | CN | claimed |
| CN-110964500-A | Preparation method of quantum dots | TCL集团股份有限公司 | 2020-04-07 | — | — | CN | claimed |
| CN-110964528-A | Quantum dot and preparation method thereof | TCL集团股份有限公司 | 2020-04-07 | — | — | CN | claimed |
| CN-110964504-A | Quantum dot and preparation method thereof | TCL集团股份有限公司 | 2020-04-07 | — | — | CN | claimed |
| CN-110964507-A | Quantum dot and preparation method thereof | TCL集团股份有限公司 | 2020-04-07 | — | — | CN | claimed |
| CN-110964501-A | Preparation method of quantum dots | TCL集团股份有限公司 | 2020-04-07 | — | — | CN | claimed |
| CN-110964506-A | Preparation method of quantum dots | TCL集团股份有限公司 | 2020-04-07 | — | — | CN | claimed |
| CN-110964508-A | Quantum dot and preparation method thereof | TCL集团股份有限公司 | 2020-04-07 | — | — | CN | claimed |
| CN-110964502-A | Quantum dot and preparation method thereof | TCL集团股份有限公司 | 2020-04-07 | — | — | CN | claimed |
| WO-2020063259-A1 | PREPARATION METHOD FOR QUANTUM DOT | TCL集团股份有限公司 | 2020-04-02 | — | — | WO | claimed |
| CN-106750912-A | A kind of heat-insulated polypropylene | 佛山市高明区生产力促进中心 | 2017-05-31 | — | — | CN | claimed |
| CN-106751083-A | A kind of heat-insulated polystyrene | 佛山市高明区生产力促进中心 | 2017-05-31 | — | — | CN | claimed |
| US-20140154342-A1 | SANDALWOOD OIL AND ITS USES RELATED TO SKIN DISORDERS | SANTALIS PHARMACEUTICALS INC. (US) | 2014-06-05 | — | — | US | claimed |
| EP-2736504-A1 | SANDALWOOD OIL AND ITS USES RELATED TO SKIN DISORDERS | Santalis Pharmaceuticals Inc. (US) | 2014-06-04 | — | — | EP | claimed |
| WO-2013016656-A1 | SANDALWOOD OIL AND ITS USES RELATED TO SKIN DISORDERS | SANTALIS PHARMACEUTICALS INC. (US) | 2013-01-31 | — | — | WO | claimed |
| EP-0506207-B1 | Pharmaceutical vehicles for reducing transdermal flux | ACCESS PHARMA INC (US) | 1999-11-17 | — | — | EP | claimed |
| EP-0872248-A2 | Pharmaceutical vehicles for reducing transdermal flux | Access Pharmaceuticals, Inc. (US) | 1998-10-21 | — | — | EP | claimed |
| EP-0506207-A2 | Pharmaceutical vehicles for reducing transdermal flux | CHEMEX PHARMACEUTICALS, Inc. (US) | 1992-09-30 | — | — | EP | claimed |
| US-4895727-A | Using water soluble zinc compound | CHEMEX PHARMACEUTICALS, INC. (US) | 1990-01-23 | — | — | US | claimed |